News
- Author:
- Walter Alexander
Publish date: April 14, 2023
Early detection and management of sleep disorders could reduce asthma incidence.
News
- Author:
- Walter Alexander
Publish date: April 7, 2023
‘Women think they are insured until they get a diagnosis,’ says the author of a new paper.
News
- Author:
- Walter Alexander
Publish date: March 30, 2023
Early biologic therapy after CT identification of mucus plugging may improve asthma control.
News
- Author:
- Walter Alexander
Publish date: March 24, 2023
Independent of pulmonary function, improvement in exercise capacity and quality of life after lung volume reduction using endobronchial valves were...
News
- Author:
- Walter Alexander
Publish date: March 21, 2023
D-cycloserine was associated with breathlessness improvement.
News
- Author:
- Walter Alexander
Publish date: March 15, 2023
FDA requires that women be notified in writing when mammograms identify dense tissue.
News
- Author:
- Walter Alexander
Publish date: February 22, 2023
Clinically important improvements seen in asthma control and quality of life over 16 weeks compared to usual care.
News
- Author:
- Walter Alexander
Publish date: February 21, 2023
Missed diagnoses may mean complicated clinical course or mortality.
News
- Author:
- Walter Alexander
Publish date: February 7, 2023
It is important for dermatologists and oncologists to be aware of the severe and atypical dAEs associated with this novel therapy. Read More
News
- Author:
- Walter Alexander
Publish date: January 17, 2023
The largest combined analysis of birth outcome data found no apparent increase in birth defects or pregnancy loss with belimumab, and a separate ca...
News
- Author:
- Walter Alexander
Publish date: December 7, 2022
Among the updates, the section on diagnostic criteria added a proposed new category “PRISm,” encompassing individuals who present with structural l...
News
- Author:
- Walter Alexander
Publish date: December 2, 2022
SABR should be considered for patients with larger, inoperable kidney cancers who have no treatment options.
News
- Author:
- Walter Alexander
Publish date: November 30, 2022
“The right drug at the right time with the right dose for the right bug for the right duration.”
News
- Author:
- Walter Alexander
Publish date: November 28, 2022
The estimated savings to Medicare during 2015-2020 that resulted from competition with five of the first-to-market biosimilars with skinny labels w...
News
- Author:
- Walter Alexander
Publish date: November 8, 2022
Compared with conventional synthetic disease-modifying antirheumatic drugs, biologic/targeted synthetic DMARDS lower dementia risk.
